Dry Macular Degeneration

Also known as: Macular Degeneration, Dry / Atrophy, Geographic / Geographic Atrophy / Nonexudative age-related macular degeneration / Dry age-related macular degeneration

DrugDrug NameDrug Description
DB15165Avacincaptad pegolAn RNA aptamer inhibiting the complement C5 indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.
DrugDrug NameTargetType
DB15165Avacincaptad pegolComplement C5target
DrugDrug NamePhaseStatusCount
DB12608Emixustat1Completed1
DB11826Lampalizumab1Completed1
DB18239ONL-12041Completed1
DB16694Pegcetacoplan1Completed1
DB00877Sirolimus1 / 2Completed1
DB00484Brimonidine2Terminated1
DB15401Danicopan2Active Not Recruiting1
DB12608Emixustat2Completed1
DB05076Fenretinide2Completed1
DB11826Lampalizumab2Completed2
DB11826Lampalizumab2Terminated1
DB00281Lidocaine2Terminated1
DB00331Metformin2Completed1
DB05650OT-5512Completed1
DB17955Palucorcel2Completed1
DB17955Palucorcel2Withdrawn1
DB16694Pegcetacoplan2Completed1
DB00635Prednisone2Recruiting1
DB00877Sirolimus2Terminated1
DB11926Tesidolumab2Completed2
DB00620Triamcinolone2Recruiting1
DB15165Avacincaptad pegol2 / 3Completed1
DB00254Doxycycline2 / 3Completed1
DB12608Emixustat2 / 3Completed1
DB15165Avacincaptad pegol3Active Not Recruiting1
DB15165Avacincaptad pegol3Completed1
DB18468Gildeuretinol3Active Not Recruiting1
DB11826Lampalizumab3Terminated3
DB16694Pegcetacoplan3Completed2
DB17832Tinlarebant3Recruiting1
DB00162Vitamin A3Active Not Recruiting1
DB16694PegcetacoplanNot AvailableRecruiting1
DB01270RanibizumabNot AvailableUnknown Status1